STOCK TITAN

Life360 SEC Filings

LIFX OTC Link

Welcome to our dedicated page for Life360 SEC filings (Ticker: LIFX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Life360's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.

Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Life360's regulatory disclosures and financial reporting.

Rhea-AI Summary

Life360, Inc. director John Philip Coghlan exercised a stock option and acquired 31,938 shares of common stock at $0.18 per share through a derivative exercise on March 5, 2026. After this transaction, he directly holds 36,202 shares of common stock, which includes 1,672 restricted stock units that each represent a contingent right to receive one share upon vesting.

He also has indirect ownership of common stock, with 9,065 shares held by the John Coghlan Living Trust and 55,494 shares held by The John Philip Coghlan 2025 Grantor Retained Annuity Trust. The reported numbers were adjusted because a previously reported transfer of 1,672 directly held shares to the living trust has not yet occurred.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
Rhea-AI Summary

Life360 reported record 2025 results with its first full year of profitability and strong growth across key metrics. Total 2025 revenue reached $489.5 million, up 32% year-over-year, driven mainly by subscription revenue of $369.3 million and rapidly expanding data and partnership revenue.

Adjusted EBITDA more than doubled to $93.2 million, up 105% year-over-year, for a 19% margin. Net income was $150.8 million, helped by a one-time, non-cash tax benefit of $118.4 million. In Q4 2025, revenue grew 26% to $146.0 million and Adjusted EBITDA rose to $32.4 million, a 22% margin.

Monthly Active Users increased 20% to about 95.8 million, and Paying Circles grew 26% to 2.8 million, supporting Annualized Monthly Revenue of $478.0 million, up 30%. Year-end cash, cash equivalents and restricted cash rose to $495.8 million from $160.5 million, aided by operating cash flow and June 2025 convertible notes.

For 2026, Life360 guides to revenue of $640–$680 million, including $460–$470 million of subscription revenue and $140–$160 million of other revenue, with Adjusted EBITDA of $128–$138 million (around a 20% margin) and targeted 20% MAU growth.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

Life360, Inc. director Charles J. Prober exercised stock options for 7,930 shares of common stock at an exercise price of $11.18 per share on February 13, 2026, then sold 7,930 shares in open-market transactions at an average price of $49.02 per share under a pre-arranged Rule 10b5-1 trading plan adopted on March 14, 2025. Following these transactions, he directly holds 105,456 shares of common stock, including 1,357 restricted stock units that each convert into one share upon vesting, and retains 71,370 stock options subject to the vesting schedule described.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

A shareholder has filed to sell 7,930 shares of common stock, with an aggregate market value of 388,728.60, through Fidelity Brokerage Services LLC on NASDAQ around 02/13/2026. The filing lists 78,400,518 shares outstanding, providing context for the planned sale size.

The same shareholder sold 7,930 common shares in each of the past three months, on 11/13/2025, 12/15/2025, and 01/13/2026, for gross proceeds of 610,054.90, 541,619.00, and 491,501.40, respectively. The shares to be sold were acquired on 02/13/2026 via an option granted on 04/12/2022 and paid for in cash.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
Rhea-AI Summary

Life360, Inc. reported that AustralianSuper Pty Ltd, an Australian entity classified as an employee benefit plan and/or investment company, has filed a Schedule 13G as a passive shareholder.

As of 12/31/2025, AustralianSuper beneficially owns 4,655,983 Life360 ordinary shares, representing 5.94% of the class. It holds sole power to vote and to dispose of all these shares, with no shared voting or dispositive power and no other persons identified on whose behalf it holds more than 5%.

AustralianSuper certifies the shares were acquired and are held in the ordinary course of business, and not for the purpose of changing or influencing control of Life360, nor in connection with any transaction aimed at that purpose, other than activities solely related to proxy access nominations.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
ownership
-
Filing
Rhea-AI Summary

Life360, Inc. filed a current report to furnish a media release related to its results of operations and financial condition. The company is providing the text of this release, dated January 22, 2026, as Exhibit 99.1 under Items 2.02 and 7.01. This information is being furnished rather than filed, which means it is not subject to certain liability provisions of the Exchange Act and is not automatically incorporated into other securities filings. The company also notes that the text associated with these items will be made available on its website, with the option to discontinue that access at any time.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

Charles J. Prober, a director of Life360, Inc. (LIF), reported transactions on 09/15/2025 conducted under a Rule 10b5-1 trading plan. The Form 4 shows an acquisition of 7,930 shares via exercise of stock options at an $11.18 exercise price and a contemporaneous sale of 7,930 shares at $100.24 per share. After the transactions the reporting person’s direct beneficial ownership is reported as 105,456 shares in one line and 111,020 options-related shares in the derivative table; the filing also notes total holdings include 2,036 restricted stock units that convert to common stock upon vesting. The Form 4 states the 10b5-1 plan was adopted on March 14, 2025, and the option vesting schedule is described in the filing.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Life360, Inc. submitted a Rule 144 notice proposing the sale of 7,930 common shares through Fidelity Brokerage Services on 09/15/2025 with an aggregate market value of $794,903.20. The filing reports 77,548,651 shares outstanding. The securities were acquired on 09/15/2025 as options originally granted on 04/12/2022 and the stated payment method is cash. The form also discloses two prior sales by Charles Prober within the past three months: 7,930 shares sold on 07/14/2025 for $510,771.30 and 7,930 shares sold on 08/13/2025 for $667,150.90. The filer attests there is no undisclosed material adverse information.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other

FAQ

What is the current stock price of Life360 (LIFX)?

The current stock price of Life360 (LIFX) is $22.91 as of January 26, 2026.

What is the market cap of Life360 (LIFX)?

The market cap of Life360 (LIFX) is approximately 7.6B.

LIFX Rankings

LIFX Stock Data

7.62B
174.45M
Software - Application
Technology
Link
United States
San Mateo

LIFX RSS Feed